# TRIAD - Treatment of Insomnia and Depression

> **NCT00767624** · PHASE2,PHASE3 · COMPLETED · sponsor: **Stanford University** · enrollment: 150 (actual)

## Conditions studied

- Sleep Initiation and Maintenance Disorders
- Depression

## Interventions

- **DRUG:** Antidepressant
- **BEHAVIORAL:** Desensitization Therapy for Insomnia
- **BEHAVIORAL:** Cognitive Behavioral Therapy for Insomnia

## Key facts

- **NCT ID:** NCT00767624
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2016-12-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00767624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00767624, "TRIAD - Treatment of Insomnia and Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00767624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*